4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Gelteq Limited (GELS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Clayton, Australia with about 7 employees. Its market capitalization is roughly $6 million. In the fiscal year ended 2025-06-30, GELS reported AUD 0M in revenue and (AUD 7M) in net income.
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products.
Interactive charts & full statements → Open the GELS valuation workbench →
| Income statement | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Revenue | AUD 0M | AUD 0M | AUD 0M | AUD 0M |
| Gross Profit | — | AUD 0M | AUD 0M | AUD 0M |
| Operating Income (EBIT) | (AUD 5M) | (AUD 3M) | (AUD 3M) | (AUD 3M) |
| Net Income | (AUD 7M) | (AUD 4M) | (AUD 4M) | (AUD 3M) |
AUD; AUDM / AUDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Assets | AUD 22M | AUD 21M | AUD 22M | AUD 23M |
| Total Liabilities | AUD 6M | AUD 6M | AUD 4M | AUD 3M |
AUD; AUDM / AUDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GELS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms